Epilepsy in Rett syndrome: Clinical and genetic features

Epilepsy and Behavior

Volumn 19, Issue 3, 2010, Pages 296-300

  Pintaudi, Maria ^a   Calevo, Maria Grazia ^b   Vignoli, Aglaia ^c   Parodi, Elena ^a   Aiello, Francesca ^a   Baglietto, Maria Giuseppina ^a   Hayek, Yussef ^d   Buoni, Sabrina ^d   Renieri, Alessandra ^e   Russo, Silvia ^f   Cogliati, Francesca ^f   Giordano, Lucio ^g   Canevini, MariaPaola ^c   Veneselli, Edvige ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c St Paolo Hospital   (Italy)

^d UNIVERSITY HOSPITAL OF SIENA   (Italy)

^e UNIVERSITY OF SIENA   (Italy)

^f ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^g General Hospital of Brescia   (Italy)

Author keywords

Drug resistance; Epilepsy; Genotype phenotype correlation; Rett syndrome; Risk factors; Seizure semiology

Indexed keywords

METHYL CPG BINDING PROTEIN 2;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL FEATURE; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; EPILEPSY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; ONSET AGE; PHENOTYPE; PRESCHOOL CHILD; RETT SYNDROME; RISK FACTOR; SCHOOL CHILD; SEIZURE;

ADULT; AGE OF ONSET; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; GENOTYPE; HUMANS; MALE; METHYL-CPG-BINDING PROTEIN 2; MUTATION; PHENOTYPE; PROTEIN-SERINE-THREONINE KINASES; RETROSPECTIVE STUDIES; RETT SYNDROME; YOUNG ADULT;

EID: 78649906174     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2010.06.051     Document Type: Article

References (25)

1. Hagberg B., Hagberg G. Rett syndrome: epidemiology and geographical variability. Eur Child Adolesc Psychiatry 1997, 6:S5-S7.
2. Hagberg B., Hanefeld F., Percy A., Skjeldal O. An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting, Baden Baden, Germany, 11 September 2001. Eur J Paediatr Neurol 2002, 6:293-297.
3. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999, 23:185-188.
4. Bienvenu T., Carrie A., De Roux N., et al. MECP2 mutations account for most cases of typical forms of Rett syndrome. Hum Mol Genet 2000, 9:1377-1384.
5. Scala E., Ariani F., Mari F., et al. CDKL5/STK9 is mutated in Rett syndrome variant with infantile spasms. J Med Genet 2005, 42:103-107.
6. Ariani F., Hayek G., Rondinella D., et al. FOXG1 is responsible for the congenital variant of Rett syndrome. Am J Hum Genet 2008, 83:89-93.
7. Jian L., Nagarajan L., de Klerk N., et al. Predictors of seizure onset in Rett syndrome. J Pediatr 2006, 149:542-547.
8. Bahi-Buisson N., Guellec I., Nabbout R., et al. Parental view of epilepsy in Rett syndrome. Brain Dev 2008, 30:126-130.
9. Jian L., Nagarajan L., de Klerk N., Ravine D., Christodoulou J., Leonard H. Seizures in Rett syndrome: an overview from a one-year calendar study. Eur J Paediatr Neurol 2007, 11:310-317.
10. Huppke P., Köhler K., Brockmann K., Stettner G.M., Gärtner J. Treatment of epilepsy in Rett syndrome. Eur J Paediatr Neurol 2007, 11:10-16.
11. Glaze D.G., Percy A.K., Skinner S., et al. Epilepsy and the natural history of Rett syndrome. Neurology 2010, 74:909-912.
12. Nectoux J., Bahi-Buisson N., Guellec I., et al. The p.Val66Met polymorphism in the BDNF gene protects against early seizures in Rett syndrome. Neurology 2008, 70:2145-2151.
13. Zeev B.B., Bebbington A., Ho G., et al. The common BDNF polymorphism may be a modifier of disease severity in Rett syndrome. Neurology 2009, 72:1242-1247.
14. Engel J. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001, 42:796-803. for the International League against Epilepsy ILAE.
15. Berg A.T., Kelly M.M. Defining intractability: comparisons among published definitions. Epilepsia 2006, 47:431-436.
16. Bahi-Buisson N., Nectoux J., Rosas-Vargas H., et al. Key clinical features to identify girls with CDKL5 mutations. Brain 2008, 131:2647-2661.
17. Bahi-Buisson N., Kaminska A., Boddaert N., et al. The three stages of epilepsy in patients with CDKL5 mutations. Epilepsia 2008, 49:1027-1037.
18. Pintaudi M., Baglietto M.G., Gaggero R., et al. Clinical and electroencephalographic features in patients with CDKL5 mutations: two new Italian cases and review of the literature. Epilepsy Behav 2008, 12:326-331.
19. Evans J.C., Archer H.L., Colley J.P., et al. Early onset seizures and Rett-like features associated with mutations in CDKL5. Eur J Hum Genet 2005, 13:1113-1120.
20. Artuso R., Mencarelli M.A., Polli R., et al. Early-onset seizure variant of Rett syndrome: definition of the clinical diagnostic criteria. Brain Dev 2010, 32:17-24.
21. Steffenburg U., Hagberg G., Hagberg B. Epilepsy in a representative series of Rett syndrome. Acta Paediatr 2001, 90:34-39.
22. Moser S.J., Weber P., Lütschg J. Rett syndrome: clinical and electrophysiologic aspects. Pediatr Neurol 2007, 36:95-100.
23. Kerr A.M., Archer H.L., Evans J.C., Prescott R.J., Gibbon F. People with MECP2 mutation-positive Rett disorder who converse. J Intellect Disabil Res 2006, 50:386-394.
24. Renieri A., Mari F., Mencarelli M.A., et al. Diagnostic criteria for the Zappella variant of Rett syndrome (the preserved speech variant). Brain Dev 2009, 31:208-216.
25. Buoni S., Zannolli R., Felice C.D., et al. Drug-resistant epilepsy and epileptic phenotype-EEG association in MECP2 mutated Rett syndrome. Clin Neurophysiol 2008, 119:2455-2458.